ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
5.10
-0.09 (-1.73%)
Apr 25, 2025, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $362.24 million as of April 25, 2025. Its market cap has decreased by -49.61% in one year.
Market Cap
362.24M
Enterprise Value
120.61M
1-Year Change
-49.61%
Ranking
Category
Stock Price
$5.10
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has decreased from $741.98M to $362.24M, a decrease of -51.18%. That is a compound annual growth rate of -13.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 368.63M | -35.27% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | 1.24B | 67.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.45B |
| UnitedHealth Group | 388.26B |
| Johnson & Johnson | 371.29B |
| AbbVie | 315.09B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 223.28B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |